In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: the role of toll-like receptor-4

The Journal of Infectious Diseases
Georg BaumgartenJesus G Vallejo

Abstract

Tumor necrosis factor (TNF)-alpha, interleukin (IL)-1beta, and nitric oxide (NO) may play a role in lipopolysaccharide (LPS)-induced cardiac depression. Toll-like receptor-4 (TLR-4) mediates the cytokine response to LPS in immune cells. TLR-4 also is expressed in human and murine myocardial tissue. Therefore, the hypothesis that LPS induces proinflammatory cytokines in the heart via TLR-4 was tested. C3H/HeJ (TLR-4 deficient) and C3HeB/FeJ mice were studied. LPS induced a robust increase in myocardial TNF-alpha and IL-1beta mRNA in C3HeB/FeJ mice. The response in C3H/HeJ mice was blunted and delayed. Myocardial TNF-alpha and IL-1beta protein levels were higher in C3HeB/FeJ mice, as were inducible NO synthase protein and NO production. Activation of myocardial NF-kappaB was observed within 30 min in C3HeB/FeJ mice but not in C3H/HeJ mice. These findings suggest that myocardial TLR-4 is involved in signaling cytokine production within the heart during endotoxic shock.

Citations

May 16, 2006·Basic Research in Cardiology·Georg BaumgartenPascal Knuefermann
Jan 23, 2009·Basic Research in Cardiology·Chien-Hua HuangDouglas L Mann
Jul 5, 2006·Heart Failure Reviews·Maria Isabel Tejero-TaldoWilliam Bernard Weglicki
Feb 3, 2009·Molecular and Cellular Biochemistry·Yi-Chang ChengChung-Jung Liu
Jan 15, 2004·Trends in Cardiovascular Medicine·Pascal KnuefermannDouglas L Mann
Sep 28, 2006·Nature Clinical Practice. Nephrology·Tarek M El-Achkar, Pierre C Dagher
Jun 12, 2008·The Journal of Biological Chemistry·Hatice Z OzsoyDouglas L Mann
Apr 3, 2009·Evidence-based Complementary and Alternative Medicine : ECAM·Yu-Tzu ShihYi-Ching Lo
Jul 16, 2002·Current Opinion in Rheumatology·César Pacheco-TenaRobert D Inman
Jan 22, 2004·Journal of Pediatric Gastroenterology and Nutrition·Dirk Haller, Christian Jobin
Dec 15, 2005·Critical Care Medicine·Anand Kumar, Aseem Kumar
Oct 31, 2009·Circulation Research·Se-Chan KimAnne A Knowlton
May 30, 2003·American Journal of Respiratory and Critical Care Medicine·Jackeline AgorretaJavier J Zulueta
Aug 19, 2007·The Journal of Clinical Investigation·Sandra B HaudekDouglas L Mann
Oct 7, 2009·The Journal of Clinical Investigation·Kent DoiRobert A Star
Oct 11, 2007·Respiratory Research·Pascal KnuefermannChristian Grohé
Jun 27, 2007·BMC Physiology·Se-Chan KimGeorg Baumgarten
Feb 8, 2008·Molecular Medicine·Michael A FlierlPeter A Ward
Apr 20, 2011·Cardiovascular Drugs and Therapy·Mathijs van de VrieBlanche Schroen
Oct 7, 2011·International Journal of Inflammation·Yan Feng, Wei Chao
Jul 25, 2006·Expert Opinion on Investigational Drugs·Gábor FöldesStefan D Anker
Jul 13, 2011·The American Journal of the Medical Sciences·William B WeglickiI Tong Mak
Jul 14, 2009·The American Journal of the Medical Sciences·Jay H KramerWilliam B Weglicki
Oct 17, 2012·Vascular Pharmacology·Ali NaviJanice Tsui

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.